Search

Author/Creator Denis, C.

2. A prospective multicentre surveillance study to investigate the risk associated with contaminated sinks in the intensive care unit. (September 2021)

Authors:
Valentin, Anne-Sophie; Santos, Sandra Dos; Goube, Florent; Gimenes, Rémi; Decalonne, Marie; Mereghetti, Laurent; Daniau, Côme; van der Mee-Marquet, Nathalie; Abdoush, H.; Alfandari, S.; Allaire, A.; Aloe, L.; Andreo, A.; Antoine, E.; Aurel, C.; Azaouzi, A.; Barry-Perdereau, V.; Berrouane, Y.; Bla...
Journal:
Clinical microbiology and infection
Issue:
Volume 27:Number 9(2021)
Page Start:
1347.e9
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 2058 Early tumor shrinkage as a predictor for long-term outcome in patients (pts) with unresectable liver metastases from wt-KRAS colorectal cancer (LM-CRC) treated with hepatic artery infusion (HAI) of Irinotecan, 5-Fluorouracil and Oxaliplatin plus intravenous Cetuximab (IV-Cet) after failure of one to three systemic protocols (European phase II clinical trial NCT00852228). (September 2015)

Authors:
Bouchahda, M.; Michel, D.; Denis, S.; Abdoulaye, K.; Mohamed, H.; Celine, L.; Christian, F.; Rosine, G.; Pasquale, I.; Sameh, A.; Carlos, C.; Salvatore, T.; Stephanie, T.; Thierry, D.B.; Denis, C.; Philippe, R.; Valerie, B.; Francois, M. Jean; Rene, A.; Francis, L.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S348
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Binding mode of Pyridoclax to myeloid cell leukemia-1 (Mcl-1) revealed by nuclear magnetic resonance spectroscopy, docking and molecular dynamics approaches. Issue 14 (21st September 2020)

Authors:
Bourafai-Aziez, A.; Sebban, M.; Benabderrahmane, M.; Marekha, B.; Denis, C.; Paysant, H.; Weiswald, L. B.; Carlier, L.; Bureau, R.; Coadou, G.; Ravault, D.; Voisin-Chiret, A. S.; Sopková-de Oliveira Santos, J.; Oulyadi, H.
Journal:
Journal of biomolecular structure & dynamics
Issue:
Volume 38:Issue 14(2020)
Page Start:
4162
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. 190P Combination of IPH5201, a blocking antibody targeting the CD39 immunosuppressive pathway, with durvalumab and chemotherapies: Preclinical rationale. (December 2022)

Authors:
Paturel, C.L.; Anceriz, N.; Eyles, J.; Lapointe, J-M.; Denis, C.; Breso, V.; Courtois, R.; Augier, S.; Brown, L.; Luheshi, N.; Watkins, A.; Cooper, Z.A.; Tu, E.; Vivier, E.; Fraenkel, P.G.
Journal:
Immuno-oncology technology
Issue:
Volume 16(2022)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗